Brandon Smith
Chief Operating Officer at PROTHENA CORPORATION PLC
Net worth: - $ as of 2024-04-29
Brandon Smith active positions
| Companies | Position | Start | End |
|---|---|---|---|
| PROTHENA CORPORATION PLC | Chief Operating Officer | 2021-09-28 | - |
| Corporate Officer/Principal | 2020-03-02 | 2021-09-28 |
Career history of Brandon Smith
Former positions of Brandon Smith
| Companies | Position | Start | End |
|---|---|---|---|
Iconic Therapeutics, Inc.
 Iconic Therapeutics, Inc. BiotechnologyHealth Technology Iconic Therapeutics, Inc. engages in the development of novel therapeutics for the treatment of serious eye disorders. Its product ICON-1, is a novel immune-conjugate fusion protein that works with the body’s immune system to address the root causes of inflammation and angiogenesis together, potentially altering the course of causes of blindness. The company was founded by Alan Garen, Kirk Dornbush, and Michael I. Sherman in 2003 and is headquartered in South San Francisco, CA. | Chief Operating Officer | 2016-12-31 | 2019-12-31 |
Impax Laboratories LLC
 Impax Laboratories LLC Pharmaceuticals: MajorHealth Technology Impax Laboratories LLC operates as a technology based specialty pharmaceutical company. It engages in the development, manufacture, and marketing of controlled-release and niche generics. The company was founded on December 14, 1999 and is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | 2012-05-31 | 2016-12-31 |
Impax Laboratories LLC
Impax Laboratories LLC Pharmaceuticals: MajorHealth Technology Impax Laboratories LLC operates as a technology based specialty pharmaceutical company. It engages in the development, manufacture, and marketing of controlled-release and niche generics. The company was founded on December 14, 1999 and is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | 2011-12-31 | 2016-12-31 |
| AMGEN INC. | Corporate Officer/Principal | 2004-12-31 | 2011-12-31 |
Training of Brandon Smith
| University of Michigan | Undergraduate Degree |
| McCombs School of Business | Masters Business Admin |
Statistics
International
| United States | 5 |
| Ireland | 2 |
| 2 |
Operational
| Corporate Officer/Principal | 4 |
| Chief Operating Officer | 2 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| PROTHENA CORPORATION PLC | Health Technology |
| AMGEN INC. | Health Technology |
| Private companies | 2 |
|---|---|
Impax Laboratories LLC
Impax Laboratories LLC Pharmaceuticals: MajorHealth Technology Impax Laboratories LLC operates as a technology based specialty pharmaceutical company. It engages in the development, manufacture, and marketing of controlled-release and niche generics. The company was founded on December 14, 1999 and is headquartered in Bridgewater, NJ. | Health Technology |
Iconic Therapeutics, Inc.
Iconic Therapeutics, Inc. BiotechnologyHealth Technology Iconic Therapeutics, Inc. engages in the development of novel therapeutics for the treatment of serious eye disorders. Its product ICON-1, is a novel immune-conjugate fusion protein that works with the body’s immune system to address the root causes of inflammation and angiogenesis together, potentially altering the course of causes of blindness. The company was founded by Alan Garen, Kirk Dornbush, and Michael I. Sherman in 2003 and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Brandon Smith
- Experience